Sunshine Biopharma Inc.
corporate_fare Company Profile
Sunshine Biopharma Inc. (NASDAQ:SBFM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 33 items for SBFM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for SBFM spans S-1, 10-Q, DEF 14A, PRE 14C.
Recent high-impact activity:
- Sunshine Registers 31.1M Series B Warrant Shares at $2.7674 Strike
- Sunshine Biopharma Q3 Loss Widens to $5.20/Share, Missing Estimates
- Sunshine Biopharma Q3 Loss Widens to $1.2M; $14.6M Cash Funds 29 Months
- Sunshine Biopharma Seeks 7,000,000-Share Equity Plan Increase at Dec 29 Meeting
- Sunshine Biopharma Sets Reverse Split to Hold Nasdaq Listing
Financial Snapshot
Short Interest & Short Volume
1.03 days to coverFINRA reported short interest of 176,303 shares in SBFM as of the October 30, 2026 settlement, a 79.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 41.3% of SBFM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for SBFM, detected from its recent SEC filings · based on capital-structure filings through 2026-10-14.
CEO Approves Warrant Stockholder Provisions · Share Combination Event Price Floor
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →